Spoonful of sugar: Healthcare reform and patent expiration will boost industry revenue

IBISWorld’s industry research report on Generic Pharmaceutical Manufacturing provides up-to-date sales and market data, allowing you to identify the product and customer segments driving revenue growth. The report identifies the leading companies in the industry, and offers strategic analysis of the key factors influencing the market. Our data forecasts are accompanied by full analysis to illustrate how the market is responding to dominant and emerging trends.


Industry Threats & Opportunities

  • Industry revenue growth has outpaced that of brand name pharmaceuticals due to the patent cliff
  • New industry operators are increasingly focused on producing generic biologic drugs, known as biosimilars
  • Consumer preference for generic drugs will continue to increase

  • shopping_cartBUY NOW TO READ MORE

    Industry Analysis & Industry Trends

    The Generic Pharmaceutical Manufacturing industry is expanding rapidly. An aging population with more chronic illnesses is driving demand for industry products, while regulatory provisions of the Patient Protection and Affordable Care Act expand consumer access to prescription insurance and provide increased opportunities for product development. Over the past five years, industry revenue growth has outpaced revenue growth for the Brand Name Pharmaceutical Manufacturing industry (IBISWorld report 32541a). Many brand name manufacturers lost patent protection for blockbuster drugs during the period, increasing consumer demand for more affordable generic versions of these high-profile products. These trends will likely continue over the next five years...

    shopping_cartBUY NOW TO READ MORE

    Industry Report - Industry SWOT Analysis Chapter

    Over the 10 years to 2022, industry value added, which measures this industry's contribution to the economy, is anticipated to increase at an annualized rate of 3.0%. During the same period, US GDP is projected to rise at an annualized rate of just 2.0%, indicating that the Generic Pharmaceutical Manufacturing industry's importance to the overall US economy is increasing significantly. This growing contribution to the national economy is a signifier that the industry is in a growing life cycle phase.

    Industry companies are rapidly growing in size and gaining the expertise to introduce new products at a progressively faster rate. As ..

    shopping_cartBUY NOW TO READ MORE

    Additional Insights for the Generic Pharmaceutical Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Generic Pharmaceutical Manufacturing Industry are

  • Control of distribution arrangements
  • Degree of globalization
  • Undertaking generic pharmaceutical and medicine research and development
  • IBISWorld analysts also discuss how external factors such as Federal funding for Medicare and Medicaid and Number of people with private health insurance in the Generic Pharmaceutical Manufacturing industry impact industry performance..

    shopping_cartBUY NOW TO READ MORE

    Look under the hood?

    Download a FREE sample report

    Industry Products

    What is the Generic Pharmaceutical Manufacturing Industry?

    Generic pharmaceutical and medicine manufacturers develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Generic drugs are produced and distributed without patent protection, and industry operators are not significantly engaged in the research and development of new drugs. The industry does not include manufacturers of nutritional supplements or cosmetic beauty products.

    Industry Products
    Mental health and lipid regulators
    Antidiabetics and respiratory
    Pain and antibacterials
    Nervous system disorders and antihypertensives
    Antiulcerants and thyroid
    Dermatologicals and hormonal contraceptives
    ADHD and anticoagulants
    Industry Activities
    Developing and producing generic drugs
    Marketing and distributing generic drugs
    Gaining regulatory approval for generic drugs

    Table of Contents

    About this Industry
    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry at a Glance
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Industry Performance
    Executive Summary
    Key External Drivers
  • Federal funding for Medicare and Medicaid
  • Number of people with private health insurance
  • Research and development expenditure
  • Median age of population
  • Trade-weighted index

  • Current Performance
  • Brand name and generic
  • New opportunities
  • Chart: Revenue Growth

  • Industry Outlook
  • Research and development
  • The regulatory environment
  • Industry landscape
  • Table: Generic Pharmaceutical Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Generic Pharmaceutical Manufacturing Industry Lifecycle vs The Economy

  • Products & Markets
    Supply Chains
    Key Buying Industries
  • Drug, Cosmetic & Toiletry Wholesaling
  • Supermarkets & Grocery Stores
  • Pharmacies & Drug Stores
  • Hospitals

  • Key Selling Industries
  • Biotechnology
  • Chemical Product Manufacturing
  • Medical Device Manufacturing
  • Medical Instrument & Supply Manufacturing
  • Navigational Instrument Manufacturing
  • Soap & Cleaning Compound Manufacturing

  • Products & Services
  • Nervous system disorders and antihypertensives
  • Other
  • Mental health and lipid regulators
  • Pain and antibacterials
  • Antidiabetics and respiratory
  • Antiulcerants and thyroid
  • Dermatologicals and hormonal contraceptives
  • ADHD and anticoagulants
  • Chart: Generic Pharmaceutical Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
    Major Markets
  • Third-party payers
  • Medicare
  • Medicaid
  • Out-of-pocket
  • Chart: Major Market Segmentation for the Generic Pharmaceutical Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Competitive Landscape
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
    ProfitPurchasesWagesResearch and development
  • Chart: Cost Structure Benchmarking – Sector vs Generic Pharmaceutical Manufacturing

  • Basis of Competition
    External competitionMethods of competition
    Barriers to Entry
  • Table: Barrier to Entry Checklist for the Generic Pharmaceutical Manufacturing Industry

  • Industry Globalization
    Major Companies
    Mylan Inc.Teva Pharmaceutical Industries Ltd.Sandoz Ltd.
  • Table: Mylan Inc. - financial performance
  • Table: Teva Pharmaceutical Industries Ltd. - financial performance
  • Table: Sandoz Ltd. - financial performance

  • Operating Conditions
    Capital Intensity
  • Chart: Level of Capital Intensity for the Generic Pharmaceutical Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Key Statistics
    Table: Industry Data for the Generic Pharmaceutical Manufacturing Industry
  • Industry Revenue (2008-2022)
  • Industry Gross Product (2008-2022)
  • Establishments (2008-2022)
  • Businesses (2008-2022)
  • Employment (2008-2022)
  • Exports (2008-2022)
  • Imports (2008-2022)
  • Wages (2008-2022)
  • Total health expenditure (2008-2022)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Table: Industry Financial Ratios
    Jargon & Glossary
    Abbreviated New Drug Application (Anda)
  • An application for the approval of a generic drug where manufacturers must scientifically prove that their products are bioequivalent to the brand products.
  • Authorized Generic
  • A prescription drug produced by brand pharmaceutical companies and marketed under a private label at a generic product price.
  • Biopharmaceuticals
  • A large protein molecule derived from living sources, as opposed to a chemical substance. Examples include insulin, human growth hormones and antibiotics.
  • Biosimilar
  • Versions of innovator biopharmaceutical products that follow patent and exclusivity expirations on innovator products.
  • Doughnut Hole
  • The Medicare Part D coverage gap; the difference of the initial coverage limit and the catastrophic coverage threshold.
  • Evergreening
  • The process whereby pharmaceutical companies slightly tweak the formulation of their high-profile products to avoid patent expiration.
  • New Drug Application (Nda)
  • An application filed for the approval of a new drug product. Once approved, the product may be marketed in the United States.
  • Patent Cliff
  • A phenomenon wherein revenue for brand name pharmaceuticals drop as the patents for high-profile drugs expire.
  • Why buy this report?

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Generic Pharmaceutical Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Generic Pharmaceutical Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Generic Pharmaceutical Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Join IBISWorld today

    Contact Us

    Want to speak to a representative? Call us.